Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that mainly damages the hands and feet, which affects 0.5% to 1.0% of the population worldwide. With the sustained development of disease-modifying antirheumatic drugs (DMARDs), significant success has been achie...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jie, Fu, Xuekun, Chen, Xinxin, Li, Zheng, Huang, Yuhong, Liang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299711/
https://www.ncbi.nlm.nih.gov/pubmed/34305919
http://dx.doi.org/10.3389/fimmu.2021.686155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299711/
https://www.ncbi.nlm.nih.gov/pubmed/34305919
http://dx.doi.org/10.3389/fimmu.2021.686155

Ejemplares similares